Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,586 recalls · Class II, newest first

Class II · Moderate risk

ARMY HEALTH With CURCUMIN

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. D-1494-2019
Class II · Moderate risk

AbeeMed cream

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. D-1493-2019
Class II · Moderate risk

Oliver's Harvest CBD+Capsaicin 0.2% Pain Relief

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Terminated Stability / shelf life Pharma-Natural Inc. NDC 63788-120-04 D-1492-2019
Class II · Moderate risk

Losartan Potassium Tablets 50 mg 1000 Tablets

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Terminated Nitrosamine impurity Macleods Pharma Usa Inc NDC 33342-045-44 D-1458-2019
Class II · Moderate risk

Losartan Potassium Tablets

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Terminated Nitrosamine impurity Macleods Pharma Usa Inc NDC 33342-045-10 D-1457-2019

Recalls by year